| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.061 | 0.4 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.4 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.4 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |